Skip to main content
. 2016 May 4;311(2):F312–F319. doi: 10.1152/ajprenal.00123.2016

Fig. 3.

Fig. 3.

Effect of renin-angiotensin system (RAS) blockade with the angiotensin-converting enzyme (ACE) inhibitor enalapril (250 mg/l for 2 wk) on MAP in male control and IUGR rats. MAP was measured at 12 mo of age (control n = 11 and IUGR n = 12) and at 18 mo of age (control n = 5 and IUGR n = 6) following the 2-wk exposure to enalapril or vehicle. *P < 0.05 vs. age-matched control. †P < 0.05 vs. 12 mo IUGR. Data values represent means ± SE.